| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1472-6483(11)60210-1 |
| P698 | PubMed publication ID | 12537774 |
| P2093 | author name string | J M Weiss | |
| O Ortmann | |||
| K Diedrich | |||
| P2860 | cites work | Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor | Q28645650 |
| Differential expression and regulation of estrogen receptors (ERs) in rat pituitary and cell lines: estrogen decreases ERalpha protein and estrogen responsiveness | Q30305690 | ||
| LHRH analogues as anticancer agents: pituitary and extrapituitary sites of action | Q34204370 | ||
| Intracellular signaling pathways mediated by the gonadotropin-releasing hormone (GnRH) receptor | Q34466846 | ||
| Biology of the gonadotropin-releasing hormone system in gynecological cancers | Q34467231 | ||
| The place of gonadotrophin-releasing hormone antagonists in reproductive medicine. | Q35019228 | ||
| Dose relationship between GnRH antagonists and pituitary suppression | Q36860197 | ||
| Gonadotropin-releasing hormone and its analogues | Q37618010 | ||
| Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats by LH-RH antagonist Cetrorelix | Q37693657 | ||
| Signal transduction mechanisms of Ca2+ mobilizing hormones: the case of gonadotropin-releasing hormone | Q37938857 | ||
| Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective | Q38160875 | ||
| Gonadotrophin-releasing hormone: its actions and receptors | Q38265398 | ||
| Molecular mechanism of gonadotropin releasing hormone (GnRH) action. I. The GnRH receptor | Q39313110 | ||
| Steroid-independent activation of ER by GnRH in gonadotrope pituitary cells | Q40791718 | ||
| Rapid down-regulation of the type I inositol 1,4,5-trisphosphate receptor and desensitization of gonadotropin-releasing hormone-mediated Ca2+ responses in alpha T3-1 gonadotropes | Q40844029 | ||
| Lack of a C-terminal tail in the mammalian gonadotropin-releasing hormone receptor confers resistance to agonist-dependent phosphorylation and rapid desensitization | Q40924312 | ||
| Gonadotropin-releasing hormone receptors with intracellular carboxyl-terminal tails undergo acute desensitization of total inositol phosphate production and exhibit accelerated internalization kinetics | Q41035109 | ||
| The agonist-induced phosphorylation of the rat follitropin receptor maps to the first and third intracellular loops | Q41051222 | ||
| Potent gonadotropin releasing hormone antagonists with low histamine-releasing activity | Q41078573 | ||
| Studies of gonadotropin-releasing hormone (GnRH) action using GnRH receptor-expressing pituitary cell lines | Q41130838 | ||
| Rapid desensitization of GnRH-stimulated intracellular signalling events in alpha T3-1 and HEK-293 cells expressing the GnRH receptor | Q41277993 | ||
| Ovarian steroids modulate gonadotropin-releasing hormone-induced biphasic luteinizing hormone secretory responses and inositol phosphate accumulation in rat anterior pituitary cells and αT3-1 gonadotrophs | Q41316066 | ||
| Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor | Q41430675 | ||
| Phosphorylation of phospholipase C-coupled receptors | Q41680658 | ||
| Intracellular Responses to Gonadotropin-Releasing Hormone in a Clonal Cell Line of the Gonadotrope Lineage | Q41694475 | ||
| Mechanism of GnRH receptor signaling: combinatorial cross-talk of Ca2+ and protein kinase C. | Q41701773 | ||
| Gonadotropin-releasing hormone receptors in human pituitary: ligand structural requirements, molecular size, and cationic effects | Q41935725 | ||
| Use of GnRH antagonists in the treatment of endometriosis | Q44241545 | ||
| Dose-related suppression of serum luteinizing hormone in women by a potent new gonadotropin-releasing hormone antagonist (Ganirelix) administered by intranasal spray | Q46280407 | ||
| Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix). | Q46493685 | ||
| Differences in structure-function relations between nonmammalian and mammalian gonadotropin-releasing hormone receptors | Q46990046 | ||
| Modulatory actions of estradiol and progesterone on phorbol ester-stimulated LH secretion from cultured rat pituitary cells | Q48399161 | ||
| Effects of progesterone on gonadotropin-releasing hormone receptor concentration in cultured estrogen-primed female rat pituitary cells | Q48442506 | ||
| Synthetic analogs of the hypothalamic luteinizing hormone releasing factor with increased agonist or antatonist properties | Q48619634 | ||
| Specific, estrogen-sensitive alterations in anterior pituitary cytoplasmic and nuclear estrogen receptors actuated by LHRH. | Q48769372 | ||
| Local Ca2+ release from internal stores controls exocytosis in pituitary gonadotrophs | Q48819860 | ||
| Modulatory actions of progesterone on gonadotropin-releasing hormone-induced arachidonic acid liberation from perifused rat pituitary cells | Q48869956 | ||
| Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation | Q49106785 | ||
| The role of LHRH agonists and antagonists. | Q54622516 | ||
| Removal of phosphorylation sites from the β2-adrenergic receptor delays onset of agonist-promoted desensitization | Q56648662 | ||
| The Functional Microdomain in Transmembrane Helices 2 and 7 Regulates Expression, Activation, and Coupling Pathways of the Gonadotropin-releasing Hormone Receptor | Q58853821 | ||
| A Locus of the Gonadotropin-releasing Hormone Receptor That Differentiates Agonist and Antagonist Binding Sites | Q58853853 | ||
| Effect of gonadotropin-releasing hormone on estrogen receptor messenger ribonucleic acid level in perifused pituitary cells | Q71561306 | ||
| Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility | Q71736673 | ||
| Pivotal role for the cytoplasmic carboxyl-terminal tail of a nonmammalian gonadotropin-releasing hormone receptor in cell surface expression, ligand binding, and receptor phosphorylation and internalization | Q73201608 | ||
| Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation | Q73296595 | ||
| Biochemical and functional aspects of gonadotrophin-releasing hormone and gonadotrophins | Q73519292 | ||
| P304 | page(s) | 1-7 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Reproductive BioMedicine Online | Q15762964 |
| P1476 | title | Gonadotrophin-releasing hormone (GnRH) and GnRH agonists: mechanisms of action | |
| P478 | volume | 5 Suppl 1 |
| Q44624341 | Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment |
| Q91692711 | Endocrine and Targeted Therapy for Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer: Insights to Sequencing Treatment and Overcoming Resistance Based on Clinical Trials |
| Q35934317 | Fertility preservation in reproductive-age women facing gonadotoxic treatments |
| Q92719703 | Phase I trial of TAK-385 in hormone treatment-naïve Japanese patients with nonmetastatic prostate cancer |
| Q92245139 | Population pharmacokinetics of pevonedistat alone or in combination with standard of care in patients with solid tumours or haematological malignancies |
| Q40191078 | Regulation of GnRH I receptor gene expression by the GnRH agonist triptorelin, estradiol, and progesterone in the gonadotroph-derived cell line alphaT3-1. |
| Q49608951 | Triptorelin: A Review of its Use as an Adjuvant Anticancer Therapy in Early Breast Cancer |
| Q61811467 | Uterine fibroids: an update on current and emerging medical treatment options |
Search more.